(Finance) – Friulchem closes the first semester with revenues of sales amounted to 15.1 million and decreased compared to the 17.0 million at 30 June 2022. The Production value stands at 16.8 million, down compared to 17.9 million on 30 June 2022.
EBITDA at 30 June 2023 amounted to 0.92 million, increased by 8% compared to 30 June 2022 (0.85 million); the increase of which is given by the contribution of the Veterinary BU compared to the human Business Unit.
L’EBITDA Margin it stands at 5.5%, an increase compared to the same period of the previous year (4.7%). L’EBIT is equal to 0.4 million (corresponding to an EBIT Margin of 2.1%) substantially in line with the previous year.
The Net income at 30 June 2023 pertaining to the Group was negative by 0.09 compared to 0.04 million at 30 June 2022.
There net financial position at 30 June 2023 it amounted to 10.5 million compared to the end of 2022 (5.4 million).